CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade DiaMedica Therapeutics Inc. - DMAC CFD

2.7920
1.76%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0660
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 2.842
Open 2.802
1-Year Change 4.14%
Day's Range 2.742 - 2.872
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 28, 2024 2.7920 0.0500 1.82% 2.7420 2.8720 2.7420
May 24, 2024 2.8420 0.1000 3.65% 2.7420 2.8720 2.7420
May 23, 2024 2.8420 0.0500 1.79% 2.7920 2.8420 2.7420
May 22, 2024 2.7920 -0.1500 -5.10% 2.9420 2.9520 2.7420
May 21, 2024 2.9420 -0.0500 -1.67% 2.9920 3.1220 2.9020
May 20, 2024 3.0120 -0.0800 -2.59% 3.0920 3.1020 3.0020
May 17, 2024 3.1620 0.1400 4.63% 3.0220 3.1920 3.0220
May 16, 2024 3.1120 0.1400 4.71% 2.9720 3.1520 2.9720
May 15, 2024 3.0020 0.0300 1.01% 2.9720 3.0920 2.9720
May 14, 2024 3.0020 -0.0400 -1.31% 3.0420 3.1520 2.9620
May 13, 2024 3.1320 0.1400 4.68% 2.9920 3.2220 2.8920
May 10, 2024 3.1120 -0.1000 -3.11% 3.2120 3.2220 2.9920
May 9, 2024 3.1031 -0.2500 -7.46% 3.3531 3.3531 2.9931
May 8, 2024 3.4131 -0.1300 -3.67% 3.5431 3.5431 2.9931
May 7, 2024 3.6431 0.0700 1.96% 3.5731 3.7031 3.5431
May 6, 2024 3.4931 0.4600 15.17% 3.0331 3.4931 3.0231
May 3, 2024 2.9931 0.3500 13.24% 2.6431 2.9931 2.6431
May 2, 2024 2.5831 0.0300 1.18% 2.5531 2.5831 2.5431
May 1, 2024 2.5231 0.0100 0.40% 2.5131 2.5831 2.4931
Apr 30, 2024 2.5231 0.0300 1.20% 2.4931 2.5231 2.4931

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

DiaMedica Therapeutics Inc. Company profile

About DiaMedica Therapeutics Inc

DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for neurological and kidney diseases, such as acute ischemic stroke (AIS) and chronic kidney disease (CKD). The Company's lead product DM199 mimics the behavior of naturally occurring human KLK1 proteins to preserve and restore circulation to stroke-damaged tissue and improve overall kidney function. KLK1 is a serine protease, or protein, produced primarily in the kidneys, pancreas and salivary glands. DM199 therapy has the potential to improve circulation and overall function of critical systems, as well as reduce inflammation and oxidative stress. The Company also has other product pipelines for IgA Nephropathy and African Americans with CKD.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, DiaMedica Therapeutics Inc revenues was not reported. Net loss increased 11% to $13.6M. Higher net loss reflects General and administrative - Balancing increase of 23% to $3.8M (expense), Research and development - Balancing increase of 7% to $8.3M (expense), Governmental assistance research incen decrease from $205K (income) to $0K.

Industry: Bio Therapeutic Drugs

301 Carlson Parkway
Suite 210
MINNEAPOLIS
MINNESOTA 55305
US

News

PCE Index Preview: Forecasts point to no change in headline or core inflation from a month earlier

The markets continue to look for signals of disinflation in the United States. The latest PCE Index data, the US Federal Reserve’s preferred inflation gauge, is released on May 31, 2024.

12:44, 29 May 2024

Gold and Silver recover from last week’s pullback but face resistance ahead of US PCE

Gold and Silver move higher after last week’s pullbacks but the precious metals are struggling with resistance ahead of the US PCE release.

15:46, 28 May 2024

Copper price slumps as traders take profits, where to next?

Copper price drops over 5% on Thursday as traders take profits following the FOMC meeting minutes.

16:17, 24 May 2024

Market analysis: EUR/GBP driven by diverging policy expectations

The EURGBP is driven by the question: which cuts first, the ECB or the BOE? Currently, swaps markets (chart below) imply that it will be the ECB (blue line).

13:46, 24 May 2024

UK CPI Preview: Will inflation return to 2% as the BoE predicts? And how will it affect GBP?

The latest round of inflation data will be released at 22 April at 7 am BST and investors are likely going to be paying close attention.

15:44, 21 May 2024

Reserve Bank of New Zealand Preview: RBNZ could become more dovish as inflation eases and growth softens

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, May 22, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

15:29, 21 May 2024

Nvidia Q1 Earnings Preview: Analysts forecast another blockbuster set of results

Nvidia (NVDA) reports its Q1 results after the closing bell on Wednesday, May 22nd. We preview what to expect from Nvidia’s earnings and analyse its stock's technicals.

14:57, 21 May 2024

People also watch

Oil - Crude

80.23 Price
+0.100% 1D Chg, %
Long position overnight fee 0.0090%
Short position overnight fee -0.0309%
Overnight fee time 21:00 (UTC)
Spread 0.040

XRP/USD

0.53 Price
+0.210% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

67,689.65 Price
-0.850% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

18,714.00 Price
-0.780% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading